Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-24

Clinical Trial Update: Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sitagliptin vs pioglitazone as add-on therapy in adults with type 2 diabetes mellitus uncontrolled on metformin plus sulfonylurea; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pioglitazone (Actos) (pioglitazone)
  • Sitagliptin (Januvia) (sitagliptin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Uncontrolled Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED